Literature DB >> 19919904

Placebo responses in randomized trials of antiepileptic drugs.

A B Guekht1, A D Korczyn, I B Bondareva, E I Gusev.   

Abstract

This meta-analysis of published, randomized, controlled trials (RCTs) of antiepileptic drugs in adults with focal drug-resistant epilepsy was performed to estimate a mean placebo effect, to evaluate variability in placebo response rates, to investigate associations between placebo effect rates and study characteristics, and to determine whether there were changes in placebo response rates over recent years in RCTs (so-called "placebo drift"). One hundred ninety-eight potentially appropriate studies were identified after MEDLINE search and carefully reviewed. Twenty-seven RCTs (with 5662 randomized patients, including 1887 patients in placebo arms) were included in the meta-analysis. A random effects meta-analytic model estimated the pooled placebo response at 12.5% (95% CI: 10.03-14.94%). A statistically significant correlation between baseline median seizure frequency and placebo response rates was not observed. "Placebo drift" was not considered statistically significant. 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19919904     DOI: 10.1016/j.yebeh.2009.10.007

Source DB:  PubMed          Journal:  Epilepsy Behav        ISSN: 1525-5050            Impact factor:   2.937


  15 in total

Review 1.  Characterization of the adverse events profile of placebo-treated patients in randomized controlled trials on drug-resistant focal epilepsies.

Authors:  Fabio Giovannelli; Gaetano Zaccara; Massimo Cincotta; Giulia Loiacono; Alberto Verrotti
Journal:  J Neurol       Date:  2014-10-14       Impact factor: 4.849

Review 2.  Response to placebo in clinical epilepsy trials--Old ideas and new insights.

Authors:  Daniel M Goldenholz; Shira R Goldenholz
Journal:  Epilepsy Res       Date:  2016-02-10       Impact factor: 3.045

3.  Does accounting for seizure frequency variability increase clinical trial power?

Authors:  Daniel M Goldenholz; Shira R Goldenholz; Robert Moss; Jacqueline French; Daniel Lowenstein; Ruben Kuzniecky; Sheryl Haut; Sabrina Cristofaro; Kamil Detyniecki; John Hixson; Philippa Karoly; Mark Cook; Alex Strashny; William H Theodore; Carl Pieper
Journal:  Epilepsy Res       Date:  2017-07-25       Impact factor: 3.045

4.  A big data approach to the development of mixed-effects models for seizure count data.

Authors:  Joseph J Tharayil; Sharon Chiang; Robert Moss; John M Stern; William H Theodore; Daniel M Goldenholz
Journal:  Epilepsia       Date:  2017-03-30       Impact factor: 5.864

Review 5.  Tolerability of new antiepileptic drugs: a network meta-analysis.

Authors:  Gaetano Zaccara; Fabio Giovannelli; Filippo Sean Giorgi; Valentina Franco; Sara Gasparini; Umberto Benedetto
Journal:  Eur J Clin Pharmacol       Date:  2017-04-04       Impact factor: 2.953

Review 6.  Levetiracetam add-on for drug-resistant focal epilepsy.

Authors:  Gashirai K Mbizvo; Bharath Chandrasekar; Sarah J Nevitt; Pete Dixon; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2020-06-30

7.  Investigation of influencing factors on higher placebo response in East Asian versus Western clinical trials for partial epilepsy: a meta-analysis.

Authors:  Yosuke Tachibana; Mamoru Narukawa
Journal:  Clin Drug Investig       Date:  2013-05       Impact factor: 2.859

Review 8.  Adverse events of placebo-treated, drug-resistant, focal epileptic patients in randomized controlled trials: a systematic review.

Authors:  Gaetano Zaccara; Fabio Giovannelli; Massimo Cincotta; Giulia Loiacono; Alberto Verrotti
Journal:  J Neurol       Date:  2014-06-11       Impact factor: 4.849

Review 9.  Levetiracetam add-on for drug-resistant focal epilepsy: an updated Cochrane Review.

Authors:  Gashirai K Mbizvo; Pete Dixon; Jane L Hutton; Anthony G Marson
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

Review 10.  Placebo effects in neurological diseases.

Authors:  Alina Dumitriu; Bogdan O Popescu
Journal:  J Med Life       Date:  2010 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.